title: MDM2 SNP309 and risk of cervical cancer.
authors.affiliation: Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway, stian.knappskog@med.uib.no.
authors.forename: Stian
authors.initials: S
authors.lastname: Knappskog
authors.forename: Per Eystein
authors.initials: PE
authors.lastname: Lønning
mesh_terms: D044466:Asian People / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000235:genetics*
chemical_list: D051736:Proto-Oncogene Proteins c-mdm2
references.citation: Tumour Biol. 2014 Jun;35(6):5331-7
references.pmid: 24532430
references.citation: Cell. 2004 Nov 24;119(5):591-602
references.pmid: 15550242
references.citation: Breast Cancer Res Treat. 2010 Feb;120(1):211-6
references.pmid: 19590949
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2717-23
references.pmid: 18086778
references.citation: Cancer Cell. 2011 Feb 15;19(2):273-82
references.pmid: 21316605
references.citation: Eur J Cancer. 2012 Sep;48(13):1988-96
references.pmid: 22119201
references.citation: Oncotarget. 2011 Mar;2(3):251-8
references.pmid: 21436469